Status:
ENROLLING_BY_INVITATION
The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Carrying Naloxone/Narcan on Their Person or in Their Vehicle
Being Trained to Respond to an Opioid Overdose
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study is a feasibility trial to assess whether, in a random sample of 180 agencies where PulsePoint is already active, revised procedures (hereinafter PulsePoint-OD) to facilitate opioid overdose...
Detailed Description
A full, detailed description of the study protocol and preregistered procedures is located in our formal protocol paper (https://doi.org/10.2196/57280) which is also cited at the end of this specific ...
Eligibility Criteria
Inclusion
- Layperson responders who are part of the PulsePoint system register with a local first responder agency using their smartphone. Anyone who is registered with a PulsePoint agency randomly selected for this project is included. Most layperson responders (eg, those who are not also off-duty first responders themselves) are only alerted to incidents in public spaces. No identifying information is collected from these users except the unique ID of the device.
Exclusion
Key Trial Info
Start Date :
August 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06523985
Start Date
August 7 2024
End Date
September 30 2026
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Bloomington
Bloomington, Indiana, United States, 47405